Home / Cardiovascular system / Diltiazem
ATC C08DB01 · Benzothiazepine Derivatives
Diltiazem shortage
As of 2 Nov 2026, Diltiazem has a reported shortage in 7 of the 16 countries we track (Canada, Germany, Italy, Spain, Austria, Belgium, Japan), covering 47 products from 18 companies.
Countries7/16
Products47packs or presentations
Companies185 listed
Short since10 Mar 20179.6 years ago
Earliest return10 Nov 2026company estimate
Main reasonManufacturing problem
United StatesNo reported shortageCanada23 products shortGermany5 products shortFranceNo reported shortageItaly6 products shortSpain4 products shortIrelandNo reported shortageAustria4 products shortBelgium3 products shortSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapan2 products shortNew ZealandNo reported shortageAustraliaNo reported shortage
Timeline
CanadaGermanyItalySpainAustriaBelgiumJapan
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Teva TEVA · NYSE / TASE, Pfizer PFE · NYSE, Sandoz SDZ · SIX Swiss, Viatris VTRS · Nasdaq, Sanofi SAN · Euronext Paris
Affected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | APO-DILTIAZ SR - 90MG/SRC (100 BTL & 500 BTL) | APOTEX INC | 10 Mar 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-DILTIAZ SR - SRC 120MG (100 BTL & 500 BTL) | APOTEX INC | 10 Mar 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-DILTIAZ SR - SRC 60MG (100 BTL & 500 BTL) | APOTEX INC | 10 Mar 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-DILTIAZEM (100) | TEVA CANADA LIMITED | 1 Mar 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ACT DILTIAZEM CD (100) | TEVA CANADA LIMITED | 1 Dec 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP DILTIAZEM CD (100) | JAMP PHARMA CORPORATION | 12 Mar 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-DILTIAZ CD (100 BTL) | APOTEX INC | 17 Mar 2026 | 31 May 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-DILTIAZ CD (100 BTL) | APOTEX INC | 31 Mar 2026 | 31 May 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP DILTIAZEM CD (Bottle 100) | JAMP PHARMA CORPORATION | 21 Apr 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | DILTIAZEM HYDROCHLORIDE INJECTION (10 x 5 mL vial / fiole) | OMEGA LABORATORIES LIMITED | 1 May 2026 | 31 Mar 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | DILTIAZEM CD (100) | SIVEM PHARMACEUTICALS ULC | 6 Jun 2026 | 1 May 2027 | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | APO-DILTIAZ CD (100 BTL) | APOTEX INC | 9 Jun 2026 | 31 May 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-DILTIAZEM CD (100) | TEVA CANADA LIMITED | 10 Jun 2026 | 10 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | DILTIAZEM CD (100) | SIVEM PHARMACEUTICALS ULC | 15 Jun 2026 | 1 May 2027 | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | PRO-DILTIAZEM CD (100) | PRO DOC LIMITEE | 3 Aug 2026 | 15 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | DILTIAZEM CD (100) | SANIS HEALTH INC | 5 Aug 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-DILTIAZ CD (100 BTL) | APOTEX INC | 25 Aug 2026 | 31 May 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PRO-DILTIAZEM CD (100) | PRO DOC LIMITEE | 27 Aug 2026 | 15 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PRO-DILTIAZEM CD (100) | PRO DOC LIMITEE | 28 Aug 2026 | 15 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PRO-DILTIAZEM CD (100) | PRO DOC LIMITEE | 8 Sep 2026 | 15 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | DILTIAZEM CD (100) | SANIS HEALTH INC | 5 Oct 2026 | 13 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | M-DILTIAZEM CD (Bottle of 100 tablets) | MANTRA PHARMA INC | 19 Oct 2026 | 15 Dec 2026 | Distribution or logistics Delay in shipping of the drug |
| CA | MAR-DILTIAZEM CD (BOTTLE X 100 CAPS) | MARCAN PHARMACEUTICALS INC | 20 Oct 2026 | 31 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| DE | Diltiazem AbZ 60 mg Tabletten | AbZ-Pharma GmbH | 11 May 2026 | 15 Jan 2027 | Other Sonstige |
| DE | Diltiazem AbZ 90mg Retardtabletten | AbZ-Pharma GmbH | 11 May 2026 | 15 Jan 2027 | Other Sonstige |
| DE | Diltiazem-ratiopharm 60 mg Tabletten | ratiopharm GmbH | 11 May 2026 | 15 Jan 2027 | Other Sonstige |
| DE | Dilzem 90mg retard | Pfizer Pharma GmbH | 3 Aug 2026 | 31 Mar 2027 | Increased demand Erhöhte Nachfrage |
| DE | Dilzem 90mg retard | Pfizer Pharma GmbH | 3 Aug 2026 | 31 Mar 2027 | Increased demand Erhöhte Nachfrage |
| IT | DILADEL | ZENTIVA ITALIA S.R.L. | 29 Feb 2024 | not given | Increased demand Elevata richiesta/problemi produttivi |
| IT | DILADEL | ZENTIVA ITALIA S.R.L. | 15 Mar 2024 | not given | Manufacturing problem Problemi produttivi |
| IT | DILTIAZEM SANDOZ BV | SANDOZ BV | 20 Nov 2025 | not given | Manufacturing problem Problemi produttivi |
| IT | DILTIAZEM EG | EG S.P.A. | 30 Jun 2026 | not given | Increased demand Elevata richiesta |
| IT | DILADEL | ZENTIVA ITALIA S.R.L. | 31 Aug 2026 | not given | Increased demand Elevata richiesta |
| IT | DILTIAZEM MYLAN GENERICS ITALIA anticipated | MYLAN S.P.A. | 10 Nov 2026 | not given | Manufacturing problem Problemi produttivi |
| ES | DINISOR RETARD 180 mg COMPRIMIDOS DE LIBERACION MODIFICADA, 30 comprimidos | Pfizer S.L. | 11 May 2025 | not given | Not stated |
| ES | CARRELDON RETARD 240 mg COMPRIMIDOS DE LIBERACION PROLONGADA, 20 comprimidos | Alfasigma Espana S.L. | 14 Jun 2026 | not given | Not stated |
| ES | CARRELDON RETARD 240 mg COMPRIMIDOS DE LIBERACION PROLONGADA, 30 comprimidos | Alfasigma Espana S.L. | 19 Jul 2026 | not given | Not stated |
| ES | DINISOR RETARD 120 mg COMPRIMIDOS LIBERACION MODIFICADA, 500 comprimidos | Pfizer S.L. | 5 Oct 2026 | not given | Not stated |
| AT | Diltiazem ratiopharm retard 90 mg - Filmtabletten, 50 Stück | Teva B.V. | 13 Oct 2025 | not given | Distribution or logistics Verzögerung bei der Auslieferung |
| AT | Diltiazem ratiopharm retard 90 mg - Filmtabletten, 20 Stück | Teva B.V. | 9 Dec 2025 | not given | Distribution or logistics Verzögerung bei der Auslieferung |
| AT | Diltiazem ratiopharm 60 mg - Tabletten, 50 Stück | Teva B.V. | 2 Mar 2026 | not given | Manufacturing problem Verzögerung bei der Herstellung |
| AT | Diltiazem ratiopharm 60 mg - Tabletten, 20 Stück | Teva B.V. | 9 Mar 2026 | not given | Manufacturing problem Verzögerung bei der Herstellung |
| BE | Diltiazem Retard EG 200 mg hard caps. prol.-rel. 100 | EG | 17 Nov 2025 | 11 Jan 2027 | Other Other reason |
| BE | Diltiazem Retard EG 300 mg hard caps. prol.-rel. 100 | EG | 17 Nov 2025 | 11 Jan 2027 | Other Other reason |
| BE | Tildiem Retard 200 mg hard caps. prol.-rel. 28 anticipated | Sanofi Belgium | 12 Nov 2026 | 14 Dec 2026 | Increased demand |
| JP | ジルチアゼム塩酸塩徐放カプセル100mg「トーワ」 limited | 佐藤薬品工業 | 17 Oct 2024 | not given | Increased demand |
| JP | ジルチアゼム塩酸塩徐放カプセル200mg「トーワ」 limited | 佐藤薬品工業 | 17 Oct 2024 | not given | Increased demand |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.